A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients
CompletedOBSERVATIONAL
Enrollment
20
Participants
Timeline
Start Date
September 30, 2012
Primary Completion Date
August 31, 2013
Study Completion Date
August 31, 2013
Conditions
Chemotherapy-Induced Nausea and Vomiting
Trial Locations (1)
26506
WVU Healthcare, Morgantown
All Listed Sponsors
lead
West Virginia University Healthcare
OTHER
NCT01757210 - A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients | Biotech Hunter | Biotech Hunter